View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/SAMHSA RIN: 0930-AA14 Publication ID: Fall 2010 
Title: Opioid Drugs in Maintenance or Detoxification Treatment of Opiate Addiction(Section 610 Review) 
Abstract: This rule will amend the Federal opioid treatment program regulations. It will modify the dispensing requirements for buprenorphine and buprenorphine combination products that are approved by the Food and Drug Administration (FDA) for opioid dependence and used in federally certified and registered opioid treatment programs. 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Long-Term Actions 
Major: No  Unfunded Mandates: No 
RFA Section 610 Review: Section 610 Review 
CFR Citation: 42 CFR 8 to 12   
Legal Authority: 21 USC 823 (9)    42 USC 257a    42 USC 290aa(d)    42 USC 290dd-2    42 USC 300xx-23    42 USC 300x-27(a)    42 USC 300y-11   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  06/19/2009  74 FR 29153   
NPRM Comment Period End  08/18/2009    
Final Action  To Be Determined    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: Yes 
Agency Contact:
Nicholas Reuter
Supervising Public Health Advisor
Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
Suite 2-1063, One Choke Cherry Road,
Rockville, MD 20857
Phone:240 276-2716
Email: nicholas.reuter@samhsa.hhs.gov